Tunable polymer–lipid hybrid nanoparticles: a research article about designing customizable delivery materials to direct RNA therapies to specific organs, showing adaptable formulation strategies and broad therapeutic compatibility.
Key Takeaways
- Engineered polymer–lipid hybrid nanoparticles modulate RNA interactions to enable delivery of mRNA
- Systematic tuning of polymer side chains and nanoparticle composition produced organ-specific delivery to lungs
- Platform demonstrated compatibility with vaccines and genome editors while supporting scalable nanoparticle synthesis